^
    No biomarker
    Penile Cancer
    paclitaxel
    Sensitive
    :
    A2
    No biomarker
    Penile Cancer
    capecitabine
    Sensitive
    :
    A2
    No biomarker
    Penile Cancer
    cetuximab
    Sensitive
    :
    A2
    No biomarker
    Penile Cancer
    cisplatin
    Sensitive
    :
    A2
    No biomarker
    Penile Cancer
    5-fluorouracil + mitomycin-c
    Sensitive
    :
    A2
    No biomarker
    Penile Cancer
    carboplatin + paclitaxel
    Sensitive
    :
    A2
    No biomarker
    Penile Cancer
    cisplatin + irinotecan
    Sensitive
    :
    A2
    No biomarker
    Penile Cancer
    cisplatin + 5-fluorouracil
    Sensitive
    :
    A2
    No biomarker
    Penile Cancer
    imiquimod
    Sensitive
    :
    A2
    No biomarker
    Penile Cancer
    5-fluorouracil
    Sensitive
    :
    A2
    No biomarker
    Penile Cancer
    TIP
    Sensitive
    :
    A2
    MSI-H/dMMR
    Penile Cancer
    pembrolizumab
    Sensitive
    :
    A2
    TMB-H
    Penile Cancer
    pembrolizumab
    Sensitive
    :
    C1
    PD-L1 expression
    Penile Cancer
    pembrolizumab
    Sensitive
    :
    C1
    TMB-H + PD-L1 expression + MSI-L/dMMR
    Penile Cancer
    nivolumab + ipilimumab
    Sensitive
    :
    C4
    TMB-H + PD-L1 expression
    Penile Cancer
    toripalimab
    Sensitive
    :
    C4
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES